Molecule Details
| InChIKey | JZCUVYNOSDWORZ-UHFFFAOYSA-N |
|---|---|
| Compound Name | 2-(3-Bromophenyl)-6-((2-hydroxyethyl)amino)-1H-benzo(DE)isoquinoline-1,3(2H)-dione |
| Canonical SMILES | O=C1c2cccc3c(NCCO)ccc(c23)C(=O)N1c1cccc(Br)c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.4 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB08701 |
|---|---|
| Drug Name | 2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE |
| CAS Number | nan |
| Groups | experimental |
| ATC Codes | nan |
| Description | nan |
Cross-references: BindingDB: 35553 CHEMBL559638 ChemSpider: 3388919 PDB: VGI PubChem:4177750 PubChem:99445172 ZINC: ZINC000003087488
Target Activities (2)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| O39930 | NS5b | Hepacivirus hominis | Pathogen | PF00998 | 7.4 | IC50 | ChEMBL |
| P26663 | Hepatitis C virus genotype 1b (isolate BK) | Pathogen | PF07652 PF01543 PF01542 PF01539 PF01560 PF01538 PF01006 PF01001 PF01506 PF08300 PF08301 PF12941 PF22027 PF02907 PF00998 | 7.4 | IC50 | BindingDB |